Once an Indonesian court approved a class action lawsuit, parents whose kids suffered fatalities or injuries from contaminated cough syrup sobbed in relief.
The fight of my child, who passed away last year at the age of four, was not in vain, said Nur Asiah.
The complaint was filed against the Indonesian government and eight pharmaceutical corporations by her family and the kin of 24 more victims.
Since 2022, acute renal damage has claimed the lives of more than 200 Indonesian youngsters.
Cough syrup contamination is not limited to Indonesia. In The Gambia and Uzbekistan, there have reportedly been about 100 fatalities.
While an investigation is ongoing in Indonesia, local officials claim that there is currently no proof connecting the instances to those in other nations. Six cough syrups produced in Indonesia and India have received alerts from the World Health Organization (WHO).